ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 151 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,414,000 | -71.2% | 566,116 | -82.8% | 0.00% | -78.9% |
| Q3 2019 | $11,835,000 | +2.0% | 3,287,622 | -24.1% | 0.02% | +11.8% |
| Q2 2019 | $11,601,000 | -23.8% | 4,328,704 | -15.9% | 0.02% | -26.1% |
| Q1 2019 | $15,227,000 | +271.4% | 5,144,173 | +99.5% | 0.02% | +283.3% |
| Q4 2018 | $4,100,000 | -19.4% | 2,578,412 | +86.4% | 0.01% | 0.0% |
| Q3 2018 | $5,089,000 | +1446.8% | 1,382,969 | +1088.8% | 0.01% | – |
| Q2 2018 | $329,000 | -87.0% | 116,334 | -82.9% | 0.00% | -100.0% |
| Q1 2018 | $2,523,000 | +305.0% | 680,025 | +214.2% | 0.00% | +200.0% |
| Q4 2017 | $623,000 | -65.8% | 216,440 | -46.7% | 0.00% | -66.7% |
| Q3 2017 | $1,824,000 | -86.8% | 406,200 | -86.5% | 0.00% | -88.0% |
| Q2 2017 | $13,844,000 | +71.3% | 3,016,191 | +57.1% | 0.02% | +66.7% |
| Q1 2017 | $8,082,000 | +73.0% | 1,919,742 | +69.8% | 0.02% | +50.0% |
| Q4 2016 | $4,671,000 | +408.3% | 1,130,923 | +896.7% | 0.01% | +400.0% |
| Q3 2016 | $919,000 | -96.4% | 113,462 | -96.5% | 0.00% | -96.6% |
| Q2 2016 | $25,183,000 | -24.1% | 3,228,635 | -24.9% | 0.06% | -30.1% |
| Q1 2016 | $33,173,000 | -39.5% | 4,297,065 | -15.4% | 0.08% | -28.4% |
| Q4 2015 | $54,817,000 | +2287.5% | 5,080,327 | +1429.2% | 0.12% | +2800.0% |
| Q3 2015 | $2,296,000 | -88.3% | 332,229 | -83.3% | 0.00% | -89.2% |
| Q1 2015 | $19,617,000 | -19.4% | 1,989,593 | +0.2% | 0.04% | -27.5% |
| Q4 2014 | $24,329,000 | -33.8% | 1,985,963 | -46.1% | 0.05% | -45.2% |
| Q3 2014 | $36,778,000 | +979.8% | 3,685,165 | +719.1% | 0.09% | +933.3% |
| Q2 2014 | $3,406,000 | +9361.1% | 449,914 | +4027.7% | 0.01% | – |
| Q1 2014 | $36,000 | -66.4% | 10,900 | -66.0% | 0.00% | – |
| Q4 2013 | $107,000 | +17.6% | 32,100 | +6.4% | 0.00% | – |
| Q3 2013 | $91,000 | -44.5% | 30,165 | +50.8% | 0.00% | -100.0% |
| Q2 2013 | $164,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
| RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
| TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
| DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
| Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
| Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
| Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
| Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
| Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |